Received May 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
she got an irritation near her shoulder; injected very high on the shoulder above the area where shots are usually given; This non-serious case was reported by a nurse via sales rep and described the occurrence of skin irritation in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced skin irritation (Verbatim: she got an irritation near her shoulder) and vaccine administered at inappropriate site (Verbatim: injected very high on the shoulder above the area where shots are usually given). The outcome of the skin irritation was resolved and the outcome of the vaccine administered at inappropriate site was not applicable. It was unknown if the reporter considered the skin irritation to be related to Shingrix. It was unknown if the company considered the skin irritation to be related to Shingrix. Additional Information: GSK Receipt Date :20-MAY-2025 Patient has had 1 dose of Shingrix. She reported the lady who did the injection injected very high on the shoulder (above the area where shots are usually given) which led to vaccine administered at inappropriate site and that she got an irritation near her shoulder that looked like cellulitis. The site has healed and she planed to get dose 2, but not to allow that same lady to administer dose.